Toggle Health Problems and D

IBD colorectal Cancer and vitamin D – Jan 2011

Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer

Therap Adv Gastroenterol. 2011 January; 4(1): 49–62.
doi: 10.1177/1756283X10377820.

PMCID: PMC3036961
Maitreyi Raman; Division of Gastroenterology, University of Calgary, 6D26, Teaching, Research and Wellness Building, 3280 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1; mkothand at ucalgary.ca
Andrew N. Milestone; St. Marks Hospital, Harrow, Middlesex, UK
Julian R.F. Walters; Division of Medicine, Imperial College Healthcare, London, Hammersmith Hospital, Imperial College London, UK
Ailsa L. Hart; St. Marks Hospital, Harrow, Middlesex, UK
Subrata Ghosh; Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada

Over the past 5 years, there has been a rapid resurgence of interest in vitamin D outside of its traditional role in metabolic bone disease. Some nontraditional roles ascribed to vitamin D include anti-inflammatory and immune-modulating effects. These effects have led to possible implications in the pathophysiology of immune-mediated diseases including multiple sclerosis and inflammatory bowel disease (IBD). In addition, vitamin D insufficiency has been linked to higher rates of cancers including colon, prostate and breast cancers. Given these diverse associations of vitamin D and disease states, this review describes recent advances with regard to vitamin D and gastrointestinal diseases, in particular IBD and colorectal cancer.


- - - - - - -

See also VitaminDWiki

Notice the lower left of the following chart from Overview of Vitamin D Deficiency

Possible Vitamin D Interactions

IBD colorectal Cancer and vitamin D – Jan 2011        
5754 visitors, last modified 14 Mar, 2012,
Printer Friendly Follow this page for updates